Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Hace 2 días · Treat the 1st century AD as years 1–100, the 17th century as 16011700, and the second millennium as 1001–2000; similarly, the 1st century BC/BCE was 100–1 BC/BCE, the 17th century BC/BCE was 1700–1601 BC/BCE, and the second millennium 2000–1001 BC/BCE.

  2. Hace 3 días · The history of South America is the study of the past, particularly the written record, oral histories, and traditions, passed down from generation to generation on the continent of South America. The continent continues to be home to indigenous peoples, some of whom built high civilizations prior to the arrival of Europeans in the late 1400s ...

  3. 9 de may. de 2024 · Encouraged by the reception he received at Nanjing, Ricci made a second attempt to reach Beijing. He entered the city in January 1601, accompanied by a Jesuit colleague, the young Spaniard Diego Pantoja. Although Ricci was not received by the emperor, he was given permission to remain in the capital.

  4. Hace 4 días · Ancient Greece usually encompasses Greek antiquity, as well as part of the region's late prehistory (Late Bronze Age). It lasted from c. 1200 BC – c. 600 AD and can be subdivided into the following periods: Greek Dark Ages (or Iron Age, Homeric Age), 1100–800 BC. Archaic period, 800–490 BC.

  5. 5 de may. de 2024 · 1601 AD. Hugh O'Neill and Hugh O'Donnell were defeated by Mountjoy at the Battle of Kinsale. 1603 AD. James I came to the throne of England following the death of Elizabeth I. Hugh O'Neill surrendered. Tudor conquest of Ireland completed. English law enforced throughout Ireland. 1606 AD.

  6. 1 de may. de 2024 · Article Number (Market Facing Number) 1FG1601-1RC26-2AU1-Z. Product Description. SIMOTICS S-1FG1 synchronous servo geared motor helical worm gear unit C29 motor type CT 600V AH36 Mmax=4.5 Nm Pn=0.41 kW. Product family. Servo helical worm geared motors. Product Lifecycle (PLM) PM300:Active Product. Notes.

  7. 15 de may. de 2024 · AG-1601, Initially developed by AHN-GOOK PHARMACEUTICAL Co., Ltd., Now, its global highest R&D status is Pending, Therapeutic Areas: Skin and Musculoskeletal Diseases.